Theranostic nanomedicine.
暂无分享,去创建一个
Fabian Kiessling | Wim E Hennink | Gert Storm | Twan Lammers | Silvio Aime | F. Kiessling | W. Hennink | G. Storm | T. Lammers | S. Aime
[1] D. Kerr,et al. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] W. Oyen,et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.
[3] K. Ulbrich,et al. Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[4] Hisataka Kobayashi,et al. Nano-sized MRI contrast agents with dendrimer cores. , 2005, Advanced drug delivery reviews.
[5] M A Fischl,et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Ashish Ranjan,et al. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound , 2011, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[7] Fabian Kiessling,et al. Nanotheranostics and image-guided drug delivery: current concepts and future directions. , 2010, Molecular pharmaceutics.
[8] I. Jacobs,et al. Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique. , 2010, Biomaterials.
[9] Duxin Sun. Nanotheranostics: integration of imaging and targeted drug delivery. , 2010, Molecular pharmaceutics.
[10] T Lammers,et al. Tumour-targeted nanomedicines: principles and practice , 2008, British Journal of Cancer.
[11] J. Davies,et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 , 2004, Nature Medicine.
[12] H. Grüll,et al. A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery. , 2009, Journal of the American Chemical Society.
[13] K. Ulbrich,et al. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. , 2009, Biomaterials.
[14] Jin Xie,et al. Nanoparticle-based theranostic agents. , 2010, Advanced drug delivery reviews.
[15] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[16] R. Vile,et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] K. Ulbrich,et al. Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy , 2008, British Journal of Cancer.
[18] M. Dewhirst,et al. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI , 2006 .
[19] E. Terreno,et al. In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[20] Mauro Ferrari,et al. Seven challenges for nanomedicine. , 2008, Nature nanotechnology.
[21] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[22] Roel Deckers,et al. Ultrasound triggered, image guided, local drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[23] M. Bock,et al. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography. , 2006, Bioconjugate chemistry.
[24] S. Wise. Nanocarriers as an emerging platform for cancer therapy , 2007 .
[25] M. Dewhirst,et al. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.
[26] Shelton D Caruthers,et al. Nanotechnological applications in medicine. , 2007, Current opinion in biotechnology.
[27] Fabian Kiessling,et al. Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy , 2010 .